Antiretroviral Therapy Impacts Pulmonary Innate Immunity Cells
Dr. Ronald Olivenstein is part of a study that shows alveolar macrophages are adversely impacted by antiretroviral therapy.
According to the WHO, respiratory disorders are leading causes of death world-wide (second only to heart attack & stroke). These include diseases such as obstructive lung diseases and pulmonary infections. As a result, our research is focused around four main pulmonary research themes. These include: chronic airways disease, lung injury and infection, neuromuscular dysfunction in respiratory diseases, and sleep-disordered breathing.
Above all, a multidisciplinary approach is used to study the basic mechanisms of a number of diseases. These include asthma, chronic obstructive pulmonary disease, pulmonary infections, cystic fibrosis, sleep apnea, respiratory muscle disorders, pulmonary fibrosis, lung injury, and rare respiratory diseases. Research at the Meakins also involves the study of human physiology and tissues in parallel with relevant animal and cell culture models. Furthermore, research is facilitated by the availability of a variety of core facilities for both clinical and fundamental studies.
Learn more about our research themes here.
Below you will see posts and news items related to our research themes.
Dr. Ronald Olivenstein is part of a study that shows alveolar macrophages are adversely impacted by antiretroviral therapy.
Lauzon lab members receive the second dose of the COVID-19 vaccine. Remember, mandatory vaccination is required by Nov 15, 2021.
Dr. Mazer has been awarded the inaugural Donald Stark Award for Excellence in Leadership in the Canadian Allergy Community.
Dr. Ben Geboe is the recipient of the 2021-2022 Dr. Margaret Becklake Fellowship in Respiratory Research.
Dr. Martin received the CTS 2021 Honorary Lecture Award in recognition of his contributions to respiratory medicine.
MUHC Foundation Health Matters interview with Jennifer Landry discusses respiratory issues after recovering from COVID-19
Dr. Dao Nguyen and colleagues discuss antimicrobial resistance and the new McGill AMR Centre
Dr. Jean Bourbeau is a newly elected Fellow of the Canadian Academy of Health Sciences, a prestigious honor in health sciences.
MUHC Foundation Health Matters interview with a patient from the Montreal Chest Institute whose asthma is under control thanks to their care
MUHC Foundation Health Matters interview with Ben Smith about why some lungs are more resilient to infection than others